Cargando…
Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target
Bladder carcinoma (BC) incidence and mortality rates are increasing worldwide. The development of novel therapeutic strategies is required to improve clinical management of this cancer. Aberrant protein expression may lead to cancer initiation and progression. Therefore, the identification of these...
Autores principales: | Puttamallesh, Vinuth N., Deb, Barnali, Gondkar, Kirti, Jain, Ankit, Nair, Bipin, Pandey, Akhilesh, Chatterjee, Aditi, Gowda, Harsha, Kumar, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397020/ https://www.ncbi.nlm.nih.gov/pubmed/32650368 http://dx.doi.org/10.3390/genes11070763 |
Ejemplares similares
-
Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma
por: Deb, Barnali, et al.
Publicado: (2019) -
Dickkopf Homolog 3 (DKK3) Acts as a Potential Tumor Suppressor in Gallbladder Cancer
por: Gondkar, Kirti, et al.
Publicado: (2019) -
Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer
por: Gondkar, Kirti, et al.
Publicado: (2021) -
Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays
por: Barbhuiya, Mustafa A., et al.
Publicado: (2018) -
Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1
por: Sathe, Gajanan, et al.
Publicado: (2020)